Ordering Recommendation

Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out zolpidem exposure. For follow-up testing of a presumptive result, Zolpidem, Urine, Quantitative (2012319) is preferred.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Random urine.

Specimen Preparation

Transfer 4 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 2 mL)

Storage/Transport Temperature

Room temperature.

Unacceptable Conditions

Samples collected in tube with additives or preservatives.

Remarks
Stability

Ambient: 1 week: Refrigerated: 1 month; Frozen: 1 month

Methodology

Qualitative Enzyme Immunoassay/Quantitative Liquid Chromatography-Tandem Mass Spectrometry

Performed

Sun-Sat

Reported

1-4 days

Reference Interval

Interpretive Data

Methodology: Immunoassay

Positive Cutoff: 20 ng/mL

Compliance Category

FDA

Note

If the specimen screens positive, then Confirmation/Quantitation by LC-MS/MS (ARUP test code 2012319) will be added to confirm result. Additional charges apply.

Hotline History

N/A

CPT Codes

80307; if reflexed, add 80368 (Reflexed Alt Code: G0480 )

Components

Component Test Code* Component Chart Name LOINC
2012212 Screen, Urine Interpretation 54247-2
2012301 Zolpidem Screen, Urine 94104-7
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

Zolpidem Urine with Reflex to Quantitation